/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

H

Hiroji Uemura

Yokohama City University Medical Center(JP)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

349

Papers

6.2K

Citations

39

h-index

112

i10-index

Hiroji Uemura is an academic researcher from Yokohama City University Medical Center. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Radiopharmaceutical Chemistry and Applications & Cancer, Lipids, and Metabolism. The author has an h-index of 39, co-authored 297 publications.

ORCID: 0000-0001-7943-1564

Research Topics

Prostate Cancer Treatment and Research Radiopharmaceutical Chemistry and Applications Cancer, Lipids, and Metabolism Prostate Cancer Diagnosis and Treatment CAR-T cell therapy research

Papers by this author

works

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer

2018 · New England Journal of Medicine · 1,305 citations

https://doi.org/10.1056/nejmoa1715546

Matthew R. Smith Fred Saad Simon Chowdhury Stéphane Oudard

Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021

2022 · European Urology · 125 citations

https://doi.org/10.1016/j.eururo.2022.04.002

Silke Gillessen Andrew J. Armstrong G. Attard Tomasz M. Beer

Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

2022 · European Urology · 114 citations

https://doi.org/10.1016/j.eururo.2022.11.002

Silke Gillessen Alberto Bossi Ian D. Davis Johann S. de Bono

PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer

2018 · BMC Urology · 58 citations

https://doi.org/10.1186/s12894-018-0414-8

Takashi Kawahara Yukari Ishiguro Shinji Ohtake Ikuma Kato

Shared decision making, physicians’ explanations, and treatment satisfaction: a cross-sectional survey of prostate cancer patients

2020 · BMC Medical Informatics and Decision Making · 58 citations

https://doi.org/10.1186/s12911-020-01355-z

Kazuhiro Nakayama Wakako Osaka Nobuaki Matsubara Tsutomu Takeuchi

A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer

2024 · Clinical Cancer Research · 48 citations

https://doi.org/10.1158/1078-0432.ccr-23-2978

Tanya B. Dorff Lisa G. Horvath Karen A. Autio Alice Bernard‐Tessier

Research topics

topics

Prostate Cancer Treatment and Research

Radiopharmaceutical Chemistry and Applications

Cancer, Lipids, and Metabolism

Prostate Cancer Diagnosis and Treatment

CAR-T cell therapy research

Chat about Author

Papers

Chat

Click to start Chat